These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25293847)

  • 1. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
    Benjaminsen S
    Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials.
    Vita A; De Peri L; Sacchetti E
    J Clin Psychopharmacol; 2011 Oct; 31(5):613-24. PubMed ID: 21869691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis.
    Gartlehner G; Crotty K; Kennedy S; Edlund MJ; Ali R; Siddiqui M; Fortman R; Wines R; Persad E; Viswanathan M
    CNS Drugs; 2021 Oct; 35(10):1053-1067. PubMed ID: 34495494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of pharmacotherapies for borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    CNS Drugs; 2008; 22(8):671-92. PubMed ID: 18601305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of borderline personality disorder: replacing confusion with prudent pragmatism.
    Starcevic V; Janca A
    Curr Opin Psychiatry; 2018 Jan; 31(1):69-73. PubMed ID: 29028643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains.
    Ingenhoven TJ; Duivenvoorden HJ
    J Clin Psychopharmacol; 2011 Aug; 31(4):489-96. PubMed ID: 21694626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?
    Abraham PF; Calabrese JR
    J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
    Nosè M; Cipriani A; Biancosino B; Grassi L; Barbui C
    Int Clin Psychopharmacol; 2006 Nov; 21(6):345-53. PubMed ID: 17012981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder.
    Pinto OC; Akiskal HS
    J Affect Disord; 1998 Dec; 51(3):333-43. PubMed ID: 10333987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label use of atypical antipsychotics in personality disorders.
    Rosenbluth M; Sinyor M
    Expert Opin Pharmacother; 2012 Aug; 13(11):1575-85. PubMed ID: 21933032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacology of borderline personality disorder.
    Soloff PH
    Psychiatr Clin North Am; 2000 Mar; 23(1):169-92, ix. PubMed ID: 10729938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for borderline personality disorder--current evidence and recent trends.
    Stoffers JM; Lieb K
    Curr Psychiatry Rep; 2015 Jan; 17(1):534. PubMed ID: 25413640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatments for personality disorders.
    Paris J
    Int Rev Psychiatry; 2011 Jun; 23(3):303-9. PubMed ID: 21923229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose.
    Bellino S; Rinaldi C; Bozzatello P; Bogetto F
    Curr Med Chem; 2011; 18(22):3322-9. PubMed ID: 21728970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of borderline personality disorder: what has changed over two decades? A retrospective evaluation of clinical practice.
    Timäus C; Meiser M; Bandelow B; Engel KR; Paschke AM; Wiltfang J; Wedekind D
    BMC Psychiatry; 2019 Dec; 19(1):393. PubMed ID: 31830934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials.
    Ingenhoven T; Lafay P; Rinne T; Passchier J; Duivenvoorden H
    J Clin Psychiatry; 2010 Jan; 71(1):14-25. PubMed ID: 19778496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Clinical Psychopharmacology in Borderline Personality Disorder.
    Del Casale A; Bonanni L; Bargagna P; Novelli F; Fiaschè F; Paolini M; Forcina F; Anibaldi G; Cortese FN; Iannuccelli A; Adriani B; Brugnoli R; Girardi P; Paris J; Pompili M
    Curr Neuropharmacol; 2021; 19(10):1760-1779. PubMed ID: 34151763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.
    Kutcher SP; Blackwood DH
    Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical psychopharmacology of borderline personality disorder: an update on the available evidence in light of the Diagnostic and Statistical Manual of Mental Disorders - 5.
    Ripoll LH
    Curr Opin Psychiatry; 2012 Jan; 25(1):52-8. PubMed ID: 22037092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.